3-Aminopiperidine-2,6-Dione Hydrochloride CAS 24666-56-6;2686-86-4 Mama> 99.0% Lenalidomide Intermediate Factory
Ruifu Chemical o le taʻutaʻua taʻutaʻua o le 3-Aminopiperidine-2,6-Dione Hydrochloride (CAS: 24666-56-6; 2686-86-4) faʻatasi ai ma le tulaga maualuga, vaeluaga o Pomalidomide (CAS: 19171-19-8).Ruifu Chemical e mafai ona tuʻuina atu i le lalolagi atoa, tau faʻatauvaʻa, auaunaga sili ona lelei, laʻititi ma tele tele o loʻo avanoa.Fa'atau 3-Aminopiperidine-2,6-Dione Hydrochloride, Please contact: alvin@ruifuchem.com
| Igoa Vailaau | 3-Aminopiperidine-2,6-Dione Hydrochloride |
| Synonyms | 3-Aminopiperidine-2,6-Dione HCl;3-Amino-2,6-Piperidinedione Hydrochloride;2,6-Dioxopiperidine-3-Ammonium Chloride |
| Numera CAS | 24666-56-6 |
| Fa'atatau CAS | 2686-86-4;25181-50-4 |
| Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
| Fuafua mole | C5H9ClN2O2 |
| Molecular Weight | 164.59 |
| Lisi Lisi | 120℃ |
| COA & MSDS | Avanoa |
| Amataga | Shanghai, Saina |
| Fa'ailoga | Ruifu Chemical |
| Aitema | Fa'amatalaga |
| Fa'aaliga | Pa'u Pa'epa'e Pa'epa'e |
| Mama / Suʻesuʻega Metotia | >99.0% (HPLC) |
| Susū (KF) | <0.50% |
| Ma'imau ile Fa'amago | <0.50% |
| Toega i luga o le mumu | <0.20% |
| Aofa'i Fa'aleaga | <1.00% |
| Alaleo Infrared | E tusa ai ma le Fauga |
| Tulaga Su'ega | Pisinisi Tulaga |
| Fa'aoga | Intermediate of Lenalidomide (CAS: 191732-72-6) |
afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu
3-Aminopiperidine-2,6-Dione Hydrochloride (CAS: 24666-56-6; 2686-86-4) o se mea vavalo mo le saunia o Lenalidomide (CAS: 191732-72-6).Lenalidomide o se ituaiga o vailaʻau faʻamaʻi na atiaʻe e kamupani vailaʻau olaola Amerika.E tele ana galuega e pei o le anti-tumour, le puipuiga o le puipuiga ma le anti-angiogenesis.E mafai ona faʻalavelaveina le faʻaogaina o cytokines inflammatory, ma faʻateleina le faʻaogaina o cytokines anti-inflammatory anti-inflammatory toto peripheral.E mafai ona taofia le tuputupu aʻe o le tele o sela myeloma ma MM1S cell.E lua su'esu'ega fa'apitoa fa'apitoa e fa'ata'ita'i lua-tauaso e lua-tauaso e su'esu'e ai su'esu'ega fa'apitoa e fa'atatau i le saogalemu ma le fa'amālōlōina o le lenalidomide e fa'aaogaina mo le tele o le myeloma.Fa'ai'uga su'esu'ega fa'afoma'i lata mai ua fa'aalia ai le lenalidomide e le gata ina fa'amaloloina le togafitia o le MDS ma le MM, ae fa'apea fo'i i le togafitia o le myeloma, leukemia, metastatic renal cell carcinoma, tumo malo, idiopathic generalized amyloidosis ma fa'ama'i fibrosis ponaivi ponaivi ma le ga'o e le'i matua.Ia Tesema 2005, na faʻatagaina e le US Food and Drug Administration (FDA) le lenalidomide e faʻaaogaina i togafitiga o le myelodysplastic syndrome (MDS).
